Showing results (131-140 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|August 16, 2023
Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune DiseasesPhil Alper, Claudia Betschart, Cédric André, et al.ACS Medicinal Chemistry Letters|August 16, 2023
Unraveling Psychedelic Responses: Targeted Protein Degradation and Genetic DiversityRobert B KargboACS Medicinal Chemistry Letters|August 16, 2023
Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating CancerRam W SabnisACS Medicinal Chemistry Letters|August 16, 2023
Inhibition Profiles of Some Novel Sulfonamide-Incorporated α-Aminophosphonates on Human Carbonic AnhydrasesMarjan Sobati, Morteza Abdoli, Alessandro Bonardi, et al.ACS Medicinal Chemistry Letters|October 18, 2023
Probing the Interactions of Thiazole Abietane Inhibitors with the Human Serine Hydrolases ABHD16A and ABHD12Tiina J Ahonen, Choa P Ng, Beatriz Farinha, et al.ACS Medicinal Chemistry Letters|October 18, 2023
The Potential of NOD-like Receptor Protein 3 Inflammasome Inhibitors in the Treatments of DiseasesAhmed F Abdel-MagidACS Medicinal Chemistry Letters|October 18, 2023
Development of Novel 11C-Labeled Selective Orexin-2 Receptor Radioligands for Positron Emission Tomography ImagingJian Rong, Tomoteru Yamasaki, Yinlong Li, et al.ACS Medicinal Chemistry Letters|October 18, 2023
Structure-Based Design and Synthesis of Potent and Selective KRAS G12D InhibitorsHengmiao Cheng, Puhui Li, Ping Chen, et al.ACS Medicinal Chemistry Letters|October 18, 2023
Synthesis and Optimization of 1-Substituted Imidazo[4,5-c]quinoline TLR7 AgonistsEmma G DeYoung, Justin M Howe, Siteng Fang, et al.ACS Medicinal Chemistry Letters|October 18, 2023
Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic PotentialRobert B KargboPageof 438